Stay updated on Nivolumab in IDH-Mutant Gliomas Clinical Trial
Sign up to get notified when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.

Latest updates to the Nivolumab in IDH-Mutant Gliomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing Revision: v3.5.3 to reflect a newer, minor update to the page's documentation/version history.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer “Revision” number was updated from v3.5.0 to v3.5.3, indicating a website software/version change rather than a change to the clinical trial information.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision label updated to v3.5.0 (replacing v3.4.3).SummaryDifference0.1%

- Check79 days agoChange DetectedFooter now shows Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.1%

- Check101 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating a minor site maintenance or version update; there are no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check109 days agoChange DetectedThe page now displays Revision: v3.4.1, replacing Revision: v3.4.0.SummaryDifference0.1%

Stay in the know with updates to Nivolumab in IDH-Mutant Gliomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab in IDH-Mutant Gliomas Clinical Trial page.